Neudle.com: drug interactions

Differential
(Click to cross reference)

abdominal protrusion

acetaminophen

acetylcholine

acetylcholine receptor antibody

acquired immunodeficiency syndrome

acromegaly

acupuncture

acyclovir

advances in neurology

adverse drug reaction

alpha methyldopa hydrazine

alpha-fetoprotein

alternative medicine

Alzheimer's disease

Alzheimer's disease, treatment of

amphetamines, dyskinesia associated with

amygdala

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, treatment of

antibiotics, neurologic complications with

anticholinergic drugs

anticholinergic drugs, side effects of

anticholinesterase

anticoagulant, complications of

anticoagulant, discontinuation

anticoagulant, reversal of

anticoagulant, treatment

anticoagulant, treatment in CVD

anticonvulsants

anticonvulsants, bioavailability

anticonvulsants, blood level determination of

anticonvulsants, cognitive function with

anticonvulsants, compliance

anticonvulsants, discontinuation in seizure-free epileptics

anticonvulsants, dosage

anticonvulsants, effectiveness

anticonvulsants, enzyme inducing

anticonvulsants, mechanism of action of

anticonvulsants, pharmacokinetics

anticonvulsants, selection of

anticonvulsants, teratogenicity of

anticonvulsants, untoward effects of

artificial intelligence

aspartate aminotransferase

atrioventricular block

atypical

autonomic dysfunction

beta adrenergic blocker

calcium antagonist, side effects of

carbamazepine

carbamazepine, controlled release

carbamazepine, toxicity

carbidopa

cardiovascular disease

carnitine deficiency

case studies

CAT scan, angiography

CAT scan, emission

catechol-o-methyltransferase inhibitor

CD4 counts

cerebellar hemorrhage

cerebral embolism, cardiac origin

cerebral ischemia

cerebrovascular accident

cerebrovascular accident, prevention of

cerebrovascular disease

chemotherapy, CNS treatment and complications with

chest pain

children

chiropractic manipulation

congenital malformation

congenital malformation, non CNS

contraindications

controversies in neurology

Coombs test, positive

coronary artery disease

coronary artery spasm

creatine phosphokinase(CPK)elevated

dementia, treatment of

deprenyl

depression

desipramine

dexamethasone suppression test

dilantin, factors influencing metabolism of

dilantin, saliva level

dilantin, serum level

drug induced neurologic disorders

drug interactions

drug overdose

drug overdose, management of

drug withdrawal

dyskinesia

dyskinesia, buccal lingual facial

dyskinesia, drug induced

dyspepsia

dyspnea

dystonia

dystonia, treatment of

Echinacea

efficacy

electrocardiogram, abnormal

electroencephalogram

electroencephalogram, abnormalities of

electroencephalogram, periodic complexes

electroencephalogram, triphasic delta waves

electromyogram

embolism, silent

emergencies, neurologic

epidemiology of neurology

epilepsy referral centers

evidence-based research

gamma amino butyric acid-mimetic drug

gangrene

gastrointestinal bleeding

gemfibrozil

gender

Generative Pretrained Transformer 4

generic drugs

genetic neurologic disorders

genetic testing

ginkgo biloba

ginseng

globus pallidus, stimulation

glucose tolerance test, abnormal

groaning

hallucination

hallucination, visual

haloperidol

headache

headache, treatment of

heart block

heart valve, prosthetic

histamine-2 receptor blockers

HMGcoA reductase inhibitors

human immunodeficiency virus type 1

hypotension, systemic

iatrogenic neurologic disorders

imipramine

immunosuppression

inappropriate antidiuretic(A.D.H.)hormone

intracerebral hemorrhage

L-dopa, controlled release

L-dopa, delayed treatment in Parkinsonism

L-dopa, drug interactions with and side effects of

L-dopa, enteral infusion, continuous

L-dopa, plasma concentration

L-dopa, potentiators of

Lennox-Gastaut syndrome

Lewy body disease, diffuse

liver function enzymes

locus ceruleus, lesion of

memory, impairment of

mental status, abnormal

microhemorrhage, intracerebral

migraine

migraine, prophylaxis

migraine, treatment of

misdiagnosis

mitochondrial disease

modafinil

monoamine oxidase inhibitors

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, treatment of

MRI

MRI, abnormal

multiple sclerosis

multiple sclerosis, treatment of

myasthenia gravis, diagnosis

myasthenia gravis, misdiagnosis of

myasthenia gravis, thymectomy in

myasthenia gravis, treatment of

myocardial infarction

myocardial infarction, acute

myopathy, drug-induced

neuroleptic malignant syndrome

neuroleptic, atypical

neurologic complications

neurologic complications of, surgery

neurologic complications of, systemic disease

neurologic disease, diagnoses of

neurologic signs

neurologist

neuromuscular blockade

neuronal degeneration

nigrostriatal pathway

nonsteroidal anti-inflammatory drug

non-vitamin K antagonist oral anticoagulants

nortriptyline

number needed to treat

olanzapine

old age, neurology of

oral contraceptives, choreiform movements with

organ transplantation

orthostatic hypotension

pain, management of chronic

parietal lobe, lesion of

Parkinson disease

Parkinson disease, complications, late

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, differential diagnosis of

Parkinson disease, drug holiday

Parkinson disease, drug induced

Parkinson disease, dystonia with

Parkinson disease, early symptoms

Parkinson disease, fluctuations in

Parkinson disease, nonmotor problems of

Parkinson disease, on-off phenomena in

Parkinson disease, pathogenesis of

Parkinson disease, postencephalitic

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, treatment of

Parkinson disease, young onset

Parkinsonism plus syndrome

Parkinsonism syndrome

paroxetine

parsidol

patient information and support

pergolide

peripheral pulse, absent

phenothiazine, dyskinesia associated with

phobias

platelet inhibiting drugs

pregnancy, anticonvulsants during

pregnancy, neurologic complications in

premarin

prevention of neurologic disorders

procyclidine

prognosis

progressive supranuclear palsy

propoxyphene

protease inhibitor, HIV-1

proton pump inhibitors

psychiatric disorder

psychiatric problems in neurologic disorders

pupil, dilated, bilateral

reserpine and reserpine like drugs

reserpine treatment in movement disorder

respirations in CNS disease

respirator

respiratory dyskinesias

respiratory failure

respiratory paralysis, pharmacologic

risk-benefit assessment

seizure, classification of

seizure, diagnosis of

seizure, differential diagnosis of

seizure, drug resistance

seizure, drug-induced

seizure, elderly

seizure, focal

seizure, intractable

seizure, intractable, treatment of

seizure, neonatal

seizure, non-treatment of

seizure, paradoxical

seizure, pregnancy

seizure, prognosis in adults

seizure, psychomotor-temporal lobe

seizure, remission

seizure, surgical treatment of

seizure, systemic disease causing

seizure, treatment of

seizure, treatment of, first

seizure, treatment of, monotherapy

seizure, women

selective serotonin reuptake inhibitors

serum alanine aminotransferase

shivering

simvastatin

sinemet

single photon emission computed tomography

sinus arrest

skin, discoloration

sleep pathology and physiology

sodium valproate

sodium valproate, intravenous

sodium valproate, toxicity

somnolence

spasticity

spasticity, treatment of

spina bifida

spinal cord, injury of

St. John's wort

start hesitation

statin therapy

statin therapy, discontinuation

statin therapy, dose

status epilepticus

status epilepticus, nonconvulsive

stimulation, deep brain

stress management

substantia nigra

subthalamic nucleus

subthalamic nucleus deep brain stimulation

temporal lobe, status

teratogenesis

teratogenic drugs

tetrahydroaminoacridine

thrombotic thrombocytopenia purpura

transient ischemic attack

trazodone

treatment of neurologic disorder

tremor

tremor, thalamic stimulation for suppression of

tricyclic antidepressant

trigeminal neuralgia

trigeminal neuralgia, treatment of

triglycerides

triptans

ultrasonography

ultrasonography, head, fetus-neonate

uremia

urine, dark

vagus nerve stimulation

venous thrombosis, non-cerebral

voice, abnormality of

Showing articles 100 to 150 of 6670 << Previous Next >>

Gabapentin
Lancet 343:89-91, Chadwick,D., 1994

Parkinson's Disease
JNNP 57:672-681, Marsden,C.D., 1994

Phenytoin and Ranitidine Interaction
Ann Int Med 120:892-893, Tse,C.S.T.&Iagmin,P., 1994

Risperidone
Lancet 343:457-460, Livingston,M.G., 1994

Pharmacogenetics and Drug Metabolism of Newer Antidepressant Agents
J Clin Psychiatry 55:38-45, DeVane,C.L., 1994

Felbamate
The Medical Letter 35:107-109, , 1993

Sumatriptan
Lancet 341:221-224, Bateman,D.N., 1993

Levodopa, Melanoma, and Parkinson's Disease
Neurol 43:674-677, Weiner,W.J.,et al, 1993

Epilepsy and Pregnancy
BMJ 307:492-495, O'Brien,M.D.&Gilmour-White,S., 1993

Felbamate:A New Antiepileptic Drug
Lancet 341:1445-1446, Brodie,M.J., 1993

Phenytoin
BMJ 305:1215-1218, Aronson,J.K.,et al, 1992

Erythromycin and Valproate Interaction
Ann Int Med 116:877-878, Redington,K.,et al, 1992

Elevated Carbamazepine Levels Associated with Diltiazem Use
Neurol 42:937-938, Shaughnessy,A.F.&Mosley,M.R., 1992

Role of Ticlopidine for Prevention of Stroke
Stroke 23:912-916, Albers,G.W., 1992

Lamotrigine
Lancet 339:1397-1400, Brodie,M.D., 1992

Ticlopidine for Prevention of Stroke
The Medical Letter, 34:65-661992., , 1992

Toxic Reaction Following the Combined Administration of Fluoxetine and Phenytoin:Two Case Reports
JNNP 55:412-413, Jalil,P., 1992

Phenytoin and Carbamazepine Decrease Oral Bioavailability of Praziquantel
Neurol 42:492-496, Bittencourt,P.R.M.,et al, 1992

Deprenyl Effects of Levodopa Pharmacodynamics, Mood, and Free Radical Scavenging
Neurol 42:541-544, Baronti,F.,et al, 1992

Periodic Triphasic Waves in Levodopa-Induced Encephalopathy
Neurol 42:444-446, Neufeld,M.Y., 1992

Olanzapine in the Treatment of Dopaminomimetic Psychosis in Patients with Parkinson's Disease
Neurol 47:1085-1087, Wolters,W.Ch.,et al, 1992

Prolonged Paralysis after Treatment with Neuromuscular Junction Blocking Agents
Crit Care Med 19:1125-1131, Gooch,J.L.,et al, 1991

A Reduction in Verapamil Concentrations with Phenytoin
NEJM 325:1179, Woodcock,B.G.,et al, 1991

Felbamate for Partial Seizures:Results of a Controlled Clinical Trial
Neurol 41:1785-1789, Leppik,I.E.,et al, 1991

The Effect of Valproic Acid on Plasma Carnitine Levels
Am J Dis Child 145:9999-1001, Opala,G.,et al, 1991

Neuroleptic Malignant Synd in Parkinson's after Withdrawal or Alteration of Dopaminergic Therapy
Arch Int Med 151:794-796, Keyser,D.L.&Rodnitzky,R.L., 1991

Interactions Between Calcium Channel Blockers and the Anticonvulsants Carbamazepine and Phenytoin
Neurol 41:740-742, Bahls,F.H.,et al, 1991

Early Development of Levodopa-Induced Dyskinesias and Response Fluctuations in Young-Onset Parkinson's Disease
Neurol 41:202-205, Kostic,V., 1991

Phenytoin Toxicity Due to Interaction with Clobazam
Neurol 41:313-314, Zifkin,B.,et al, 1991

Severe Adverse Interaction Between Pethidine and Selegiline
Lancet 337:246, Zornberg,G.L.,et al, 1991

Oral Anticoagulant Drugs
NEJM 324:1865-1875, Hirsh,J., 1991

New Uses and Old for Carbamazepine
Patient Care 24:48-81, Browne,T.R.,et al, 1990

Levodopa-Induced Dyskinesia:Review, Observations, and Speculations
Neurol 40:340-345, Nutt,J.G., 1990

Respiratory Dysfunction Due to L-Dopa Therapy for Parkinsonism:Diagnosis Using Serial Pulmonary Function Tests
Am J Med 89:109-114, Zupnick,H.M.,et al, 1990

Myopathy and Rhabdomyolysis Associated with Lovastatin-Gemfibrozil Combination Therapy
JAMA 264:71-75, Pierce,L.R.,et al, 1990

Established Anticonvulsants and Treatment of Refractory Epilepsy
Lancet 336:350-354, Brodie,M.J., 1990

Continuous Levodopa Infusions to Treat Complex Dystonia in Parkinson's Disease
Neurol 39:888-891, Sage,J.I.,et al, 1989

Drugs for Epilepsy
The Medical Letter 31:1-4, , 1989

Carbamazepine Update
Editorial, Lancet 2:595-5971989., , 1989

Lithium Carbonate Intoxication, A Case Report and Review of the Literature
Arch Int Med 149:36-46, Simard,M.,et al, 1989

Dose-Dependent Memory Impairment in Parkinson's Disease
Neurol 39:438-440, Huber,S.J.,et al, 1989

Vigabatrin
Editorial, Lancet 1:532-5331989., , 1989

Reduced Felodipine Bioavailability in Pts Taking Anticonvulsants
Lancet 2:480-482, Capewell,S.,et al, 1988

Does Levodopa Aggravate Parkinson's Disease
Neurol 38:1410-1416, Blin,J.,et al, 1988

Carbamazepine Increased Phenytoin Serum Concentration and Reduces Phenytoin Clearance
Neurol 38:1146-1150, Browne,T.R.,et al, 1988

Dystonia in Parkinson's Disease:Clinical & Pharmacological Features
Ann Neurol 23:73-78, Poewe,W.H.,et al, 1988

Myoclonus During Combined Tricyclic Antidepressant and Lithium Treatment
J Clin Psychopharmacol 8:446-447, Devanand,D.P.,et al, 1988

Cardiac Arrhythmias
In Handbook of Parkinson's Disease, W. C. Koller (ed) , Marcal Dekker, Inc, New York, 1987, p 151., , 1987

Possible Drug Interaction During Therapy with Azidothymidine & Acyclovir for AIDS
NEJM 316:547, Bach,M.C., 1987

Forms of Dystonia in Patients with Parkinson's Disease
Neurol 37:1009-1011, Kidron,D.&Melamed,E., 1987

Showing articles 100 to 150 of 6670 << Previous Next >>